Skip to Content

T. Rowe Price Health Sciences I THISX

Analyst rating as of
NAV / 1-Day Return
101.02  /  0.43 %
Total Assets
17.9 Bil
Adj. Expense Ratio
0.650%
Expense Ratio
0.650%
Fee Level
Low
Longest Manager Tenure
5.10 years
Category
Health
Investment Style
Large Growth
Min. Initial Investment
1,000,000
Status
Open
TTM Yield
0.00%
Turnover
42%
Premium

Morningstar’s Analysis

Will THISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strong execution and skillful stock-picking earn this fund an upgrade.

Summary

| |

T. Rowe Price Health Sciences’ sound execution and skillful stock-picking results in a Morningstar Analyst Rating upgrade to Silver from Bronze.

Unlock our full analysis with Morningstar Premium